Comprehensive Recovery 

Description

The Comprehensive Recovery Research Kit is a four-component panel combining Ipamorelin (10mg), Thymosin Beta 4 TB-500 (10mg), BPC-157 (10mg), and Thymosin Alpha 1 (10mg) — addressing GH axis stimulation, tissue repair biology, angiogenesis, and immune modulation within a single comprehensive protocol framework.

Kit Components

• Ipamorelin (10mg): Selective GHSR-1a agonist stimulating GH release via the ghrelin pathway without HPA axis activation. Reference compound for pure GH secretagogue research.
• TB-500 (10mg): Thymosin Beta 4 — actin dynamics, ILK/PI3K/Akt cell migration, angiogenesis, and cardiac progenitor activation.
• BPC-157 (10mg): Angiogenesis, NOS pathway, fibroblast migration, gut mucosal protection.
• Thymosin Alpha 1 (10mg): T-cell maturation, dendritic cell activation, NK cell cytotoxicity, TLR2/TLR9 signaling.

Research Context

This kit is designed for researchers studying multiple recovery-relevant biology systems simultaneously: GH axis activation (Ipamorelin), tissue repair at the cellular and vascular level (TB-500, BPC-157), and immune system optimization (Thymosin Alpha 1). The four components operate on distinct, non-competing receptor systems, enabling parallel pathway investigation within a single protocol.

Common Research Applications

• Multi-pathway recovery biology research
• GH axis + tissue repair combination studies
• Immune-supported tissue regeneration models
• Comprehensive peptide biology protocol design

For Research Use Only. Not for human or veterinary use.